From: Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky
Gene | Distribution patternb | References |
---|---|---|
Adhesion molecules | Â | Â |
   E-selectin | E, RA > C, P | [141] |
   P-selectin | E, RA = C, P | [27] |
   Counterligands for L-selectin (MECA-79 epitope) | E, P | [25] |
   HECA 452 epitope | EO, RA > C, P | [142] |
   ICAM-1 | EO, RA > C, P | |
   ICAM-2 | EO, RA = C, P | [28] |
   VCAM-1 | EO, M, P | |
   Fibronectin | EO, RA > C, M, P | |
   CD31 (PECAM-1) | EO, RA = C, P | [27] |
   CD146 | E, RA = C, P | [34] |
   Vascular adhesion protein-1 | E, P | [35] |
   CD44 | EO, P | [27] |
   VLA1–VLA6 integrins (α1–6β1) | EO, P | [23] |
   αVβ3 integrin | EO, RA > C, P | |
Chemokines | Â | Â |
   IL-8 (CXCL8) | EO, RA > C, M, P | [50] |
   MCP-1 (CCL2) | EO, RA > C, M, P | |
   SLC (CCL21) | EO, M, P | |
   ENA-78 (CXCL5) | EO, RA > C, P | [48] |
   SDF-1 (CXCL12) | EO, M, P | |
   MIP-1α (CCL3) | EO, RA > C, P | [47] |
   ELC (CCL19) | EO, P | [52] |
Chemokine receptors/binding molecules | Â | Â |
   CXCR3 | EO, P | [59] |
   CXCR4 | EO, P | |
   Duffy antigen | E, M, P | [56] |
   Heparan sulphate proteoglycan | EO, P | [55] |
Angiogenesis regulators and their receptors | Â | Â |
   FGF-1 and FGF-2 | EO, M, P | |
   Platelet-derived growth factor receptor | EO, M, P | [77] |
   Hepatocyte growth factor activator and receptor | EO, RA = C, M, P | [78] |
   Vascular endothelial growth factor | EO, P | |
   Vascular endothelial growth factor receptors (VEGFR1–VEGFR3) | E, RA > C, M, P | |
   Transforming growth factor beta 1 | EO, RA > C, P | [83] |
   Endoglin (transforming growth factor beta receptor) | EO, RA = C, P | [83] |
   Angiopoietin-1 | EO, RA > C, P | [87] |
   Tie-1 receptor | EO, RA > C, P | |
   Angiogenin | EO, P | [75] |
   Thrombospondin | EO, RA = C, P | |
   Pleiotrophin | EO, P, M | [143] |
   Angiotensin converting enzyme | EO, P | [91] |
   Ets 1 transcription factor | EO, RA > C, M, P | [92] |
   Axl tyrosine kinase | EO, P | [93] |
Proinflammatory cytokines, other mediators and their receptors | Â | Â |
   IL-1 | EO, P | [97] |
   Type 1 IL-1 receptor | EO, P | [97] |
   IL-1 receptor antagonist | EO, P | [97] |
   Tumour necrosis factor alpha | EO, RA > C, P | [100] |
   Tumour necrosis factor receptors | EO, P | |
   IL-15 | EO, P | [110] |
   IL-17 receptor | E, RA > C, P | [112] |
   Substance P receptor | E, P | [67] |
   Parathyroid hormone-related protein | E, M, P | [144] |
   Kinin B2 receptor | EO, RA = C, P | [116] |
   Corticotropin-releasing hormone receptor type 1 | EO, RA > C, M, P | [113] |
   Urocortin | EO, P | [114] |
   Endothelin-1 | E, P | [145] |
   Stem cell factor | EO, RA = C, P | [118] |
   Somatostatin receptor (sst2a) | EO, P | [119] |
   Midkine | EO, RA > C, P | [117] |
   Osteoprotegerin | EO, P | [146] |
Proteases | Â | Â |
   MMP-1 (collagenase) | EO, RA > C, M | [120] |
   MMP-3 (stromelysin) | EO, M | [122] |
   MMP-9 (gelatinase B) | EO, RA > C, P | [123] |
   MMP-13 (collagenase 3) | EO, RA > C, P | [124] |
   Membrane type 1 matrix metalloproteinase | EO, RA > C, M | [125] |
   Cathepsin B and cathepsin L | EO, RA > C, M | [120] |
   Urokinase plasminogen activator receptor | EO, RA > C, P | [127] |
   Tissue-type plasminogen activator | E, RA = C, P | [128] |
   TIMP-1 and TIMP-2 | EO, RA > C, P | [130] |
Other genes | Â | Â |
   MHC class II | EO, P | [147] |
   c-fos | EO, RA > C, P | [138] |
   Ras | EO, P | [126] |
   Pentraxin (PTX3) | EO, P | [139] |
   Thy-1 glycoprotein | E, P | [148] |
   Prostaglandin E | EO, RA > C, P | [133] |
   Cyclooxygenase-2 | EO, RA > C, P | [132] |
   Phospholipase A2 activating protein | EO, P | [134] |
   Inducible nitric oxide synthase | EO, RA > C, M, P | [136] |
   Annexin IV and annexin VI | EO, P | [140] |